- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Lords Chloro Alkali Limited — Important, 10-02-2025: Financial Result Updates
**Consolidated Financials Summary:**
Lords Chloro Alkali Limited has recently conducted a board meeting, where it approved its financial results for the quarter and nine months ended December 31, 2024.
**Revenue Growth:** The company reported a revenue from operations of ₹64.78 crore, reflecting a year-over-year increase from ₹60.62 crore in the same quarter last year, translating to a revenue growth of approximately 35.61%. This growth could be attributed to increased market demand and operational efficiencies leading to higher production output.
**Profit and EPS:** The net profit for the quarter stood at ₹20.60 crore, a significant rebound from a loss of ₹26.99 crore in the same quarter of the prior year. The earnings per share (EPS) for this period was ₹0.50, compared to a loss per share of ₹0.29 last year, indicating a strong recovery in profitability.
**Operational Costs:** Total operational expenses were ₹63.57 crore, representing a 7.78% increase compared to ₹62.19 crore in the previous year. A notable rise in costs such as raw materials and power expenses has been observed, which reflects the company’s ability to manage its cost structure effectively to enhance margins.
**Balance Sheet & Cash Flow Statement:** The balance sheet remains healthy with no outstanding defaults on loans, showcasing solid financial discipline. This stability enhances the company’s capability to fund future growth.
**Strategic Position and Outlook:** The company appears focused on market expansion and maintaining cost efficiencies, which could position it well in a recovering economic environment. The positive sentiment around improved profitability and operational efficiency is likely to attract investor interest.
**Investor Insight:** Given the substantial improvement in both revenue and profitability, along with a strong fiscal position, this may be viewed as a *prospective buy* opportunity for investors looking for recovery plays in the chemical sector.